Actively Recruiting
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
Led by Egymedicalpedia · Updated on 2024-07-26
45
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
Sponsors
E
Egymedicalpedia
Lead Sponsor
A
Aswan University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Melasma is a common acquired disorder of hyperpigmentaion caused by increased melanin production by melanocytes. Melasma is a name derived from the Greek word melas meaning black.It is characterized by the appearance of brownish or grayish symmetrical patches on sun-exposed skin, most commonly on the face. Compared to men, women are more likely to be affected.
CONDITIONS
Official Title
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of both sexes with melasma
You will not qualify if you...
- Pregnancy
- Lactation
- Use of oral contraceptive pills or phototoxic drugs within 1 month prior to study
- History of thrombosis or abnormal bleeding
- Known allergy to tranexamic acid or hydroquinone
- Endocrine diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aswan University hospitals
Aswān, Egypt
Actively Recruiting
Research Team
H
Heba Allah Mohamed Mustafa, Resident
CONTACT
M
Moustafa Adam Ali El Taieb, professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here